Vice President, Product Strategy & Marketing

Role Summary

The Vice President, Product Strategy & Marketing leads the product strategy and enterprise-wide go-to-market activities for Rocket's rare cardiac AAV gene therapy portfolio. You will shape integrated product strategy from asset shaping through launch and lifecycle, oversee the Marketing function, and partner with Commercial Affairs, Market Access, Medical Affairs, and Patient Advocacy. The role collaborates with Regulatory, Manufacturing/Tech Ops, Finance, and Legal/Compliance to evolve Rocket’s commercial model and ensure launch readiness across global markets.

Responsibilities

• Marketing and Commercial strategy: Shape the end-to-end commercialization roadmap for novel rare cardiac gene therapies, aligning market opportunity, indications, sequencing, geographies, and resourcing from development through launch and lifecycle.
• Marketing and Commercial strategy: Work with colleagues in Commercial Affairs to evolve Rocket’s gene therapy commercial model (capabilities, structure, partners, field model, patient services, distribution) and scale it appropriately leading up to launch.
• Marketing and Commercial strategy: Engage functions beyond Commercial Affairs to support launch readiness across the organization (e.g., Tech Ops/Manufacturing, Quality, Regulatory, Medical, Patient Advocacy, Finance).
• Marketing and Commercial strategy: Steer cross-functional global market development strategy for genetic cardiomyopathies, including market shaping to drive disease awareness, diagnosis, genetic testing, and referral pathways.
• Marketing and Commercial strategy: Shape global launch strategy and ensure disciplined launch execution planning: positioning, segmentation, target product profile implications, messaging architecture, and go-to-market approach.
• Marketing and Commercial strategy: Lead development of ex-US strategy and roadmap (e.g., EU5 and other priority markets), including access considerations, sequencing, partner strategy, and country launch planning.
• Marketing and Commercial strategy: Lead late-stage launch readiness operationalization, including launch governance, integrated launch plans, timeline/milestone management, and enable cross-functional decision-making forums.
• Product Strategy: Lead development and refinement of integrated product strategy for each AAV asset as a member of the GPT, connecting clinical/regulatory/CMC realities with commercial execution and market needs, ensuring cross-functional alignment within commercial affairs and across other functions.
• Product Strategy: Lead commercialization sub-team at asset level and integrated commercialization input into clinical development strategy to support access and adoption (endpoints, comparators, patient population, trial design considerations, inclusion/exclusion, trial site strategy).
• Product Strategy: Build business cases for new AAV rare cardiac programs and label expansions, including market opportunity, competitive assessment, risk/uncertainty, and scenario planning, partnering with finance and portfolio management.
• Product Strategy: Ensure customer insight generation (HCP, patient/caregiver, treatment centers, payers) is built into strategy and translated into actionable plans across functions.
• Leadership: Develop and mentor a high-performing team across product strategy, marketing, market development, and launch readiness; set clear goals, performance standards, and development pathways.
• Leadership: Represent marketing and market development strategy internally at executive level and externally with key stakeholders as appropriate (KOLs, advocacy, ecosystem partners).
• Leadership: Ensure all activities adhere to promotional and non-promotional compliance standards, medical/legal review processes, and global ethical/regulatory requirements.

Qualifications

• Required: 15+ years proven leadership experience in rare disease and/or specialty commercialization with accountability for product strategy, launch readiness, and cross-functional execution in a matrixed environment.
• Required: Expertise in cell and gene therapy (e.g., AAV gene therapies), including center-of-excellence models, patient identification, and launch constraints unique to one-time therapies.
• Required: Track record of enterprise influence - able to lead through ambiguity, align diverse stakeholders, and drive decisions across functions outside of direct reporting lines.
• Required: Strong communication and executive presence; able to synthesize complex inputs into clear recommendations for senior leadership and GPT governance.
• Required: Experience building global and ex-US commercialization roadmaps and translating them into country-level launch approaches.
• Required: Strong strategic and analytical capability: market assessment, competitive strategy, forecasting, business case development, and scenario planning for pipeline assets.
• Required: Operational rigor in late-stage launch planning: governance, milestones, risk management, and readiness across supply, distribution, patient services, and field enablement.
• Required: People leadership experience with a track record of developing talent, building teams, and establishing scalable processes.

Education

• Bachelor’s degree required; advanced degree preferred.